SCHEMBL30936643

SCHEMBL30936643

Cc1cccc(N)c1N(C)C(=O)OC(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.37
PAX8 Q06710 1/20 0.36
ALDH1A1 P00352 3/20 0.35
CYP3A4 P08684 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
TP53 P04637 1/20 0.35
CD44 P16070 1/20 0.35
TSHR P16473 1/20 0.35
S1PR4 O95977 1/20 0.35
SCN4A P35499 1/20 0.34
CREBBP Q92793 1/20 0.34
IRAK4 Q9NWZ3 1/20 0.33
AAK1 Q2M2I8 1/20 0.33
GRM6 O15303 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HPGD P15428 1/20 0.33
PIK3CD O00329 1/20 0.33
MEN1 O00255 1/20 0.32
PLA2G1B P04054 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23540776 0.84 AAK1 (0.37) BRD4PAX8ALDH1A1CREBBPAAK1
SCHEMBL30026361 0.84 AAK1 (0.37) BRD4PAX8ALDH1A1CREBBPAAK1
SCHEMBL30936694 0.84 BRD4 (0.36) BRD4PAX8TDP1CREBBPAAK1
SCHEMBL30936586 0.84 BRD4 (0.36) BRD4PAX8ALDH1A1TSHRCREBBP
SCHEMBL31720604 0.77 TDP1 (0.46) ALDH1A1TDP1TSHRKDM4EMEN1
SCHEMBL13311040 0.76 PAX8 (0.41) BRD4PAX8ALDH1A1TP53TSHR
SCHEMBL28943941 0.75 ACHE (0.37) BRD4PAX8ALDH1A1CYP3A4TDP1
SCHEMBL12117478 0.74 LIPE (0.43) BRD4PAX8ALDH1A1TP53
SCHEMBL30961659 0.74 CYP3A4 (0.39) BRD4ALDH1A1CYP3A4TSHRAAK1
SCHEMBL20045665 0.74 CYP3A4 (0.39) BRD4ALDH1A1CYP3A4TSHRAAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof NINE SQUARE THERAPEUTICS CORPORATION (US) 2025-11-06 US disclosed
EP-4608389-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF Nine Square Therapeutics Corporation (US) 2025-09-03 EP disclosed
WO-2024092235-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF NINE SQUARE THERAPEUTICS CORPORATION (US) 2024-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof TRPM2, TRPM6, TRPM5 BRD4 351/4885PAX8 3274/4885ALDH1A1 3137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.